Hepatic adenoma is a rare, benign tumor that develops in the liver, most commonly affecting women who use birth control pills. Although it is not cancerous, this condition requires careful monitoring because of the risks of bleeding and, in rare cases, transformation into liver cancer.

Epidemiology

Hepatic adenoma is an uncommon liver condition that affects a very small portion of the population. The overall incidence is estimated to be about one to 1.3 per million people in the general population. However, the numbers change dramatically when looking at women who use oral contraceptives. In women taking birth control pills, the incidence rises to approximately 34 per million, making them 30 to 40 times more likely to develop these tumors compared to women who do not use these medications.^[4]

The condition shows a strong pattern based on gender and age. Women are affected far more often than men, with a ratio of approximately ten women for every one man diagnosed with hepatic adenoma.^[5] The tumors typically appear in women of childbearing age, usually between 22 and 44 years old.^[4] This age and gender distribution is closely linked to the use of hormone-based contraceptives during reproductive years.

The incidence of hepatic adenoma increased significantly after oral contraceptives were introduced in the 1960s. Before that time, the condition was extremely rare. A study examining autopsy records from 1907 to 1958 found only two cases of hepatic adenoma among 50,000 specimens.^[4] The connection between birth control pills and hepatic adenoma was first suggested in the 1970s, and since then, the understanding of this relationship has grown considerably.

In recent years, the pattern of hepatic adenoma has begun to shift. While the condition was once almost exclusively seen in women using oral contraceptives, there has been an increase in cases among men. This change appears to be associated with rising rates of obesity and metabolic syndrome, which is a cluster of conditions including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. These metabolic factors are now recognized as important contributors to hepatic adenoma development, especially in male patients.^[4]

Causes

The development of hepatic adenoma is strongly connected to substances and conditions that affect sex hormones in the body, particularly estrogen and testosterone. Changes in genes, called mutations, may also contribute to the formation of these tumors, but the exact mechanisms are still being studied.^[1]

Birth control pills containing estrogen are the most significant cause of hepatic adenoma. The risk increases with both the dose of estrogen in the pills and the length of time a woman takes them. Older formulations of oral contraceptives contained much higher doses of estrogen—often 100 micrograms or more in the 1960s—which contributed to higher rates of hepatic adenoma. As pill formulations changed to contain lower doses, typically 30 micrograms or less, the risk decreased somewhat, though it remains elevated compared to women who do not use hormonal contraception.^[4]

Pregnancy is another condition that can trigger hepatic adenoma or cause existing tumors to grow. During pregnancy, the body naturally produces higher levels of sex hormones, which can stimulate the development or expansion of these liver tumors. This is why pregnant women with known hepatic adenomas need close monitoring throughout their pregnancy.^[1]

Anabolic steroids, which are drugs that act like testosterone, represent another important cause of hepatic adenoma. These substances are sometimes used illegally by athletes and bodybuilders to build muscle mass. Men who use anabolic steroids face an increased risk of developing these liver tumors. Similarly, other hormone-related medications can contribute to hepatic adenoma formation. These include clomiphene, a fertility drug with estrogen-like effects, and recombinant human growth hormones, which are prescribed to treat growth disorders.^[1]

Certain genetic conditions can also lead to hepatic adenoma. Type I and type III glycogen storage diseases are inherited disorders that affect how the liver processes and stores glycogen, a form of sugar. These conditions can impair liver function and increase the likelihood of developing hepatic adenomas. The tumors associated with glycogen storage diseases often appear at a younger age and may be multiple in number.^[1]

Obesity and metabolic syndrome have emerged as increasingly important causes of hepatic adenoma, particularly in men. The metabolic changes associated with excess body weight and insulin resistance appear to create an environment in the liver that favors tumor development. This connection has become more apparent as obesity rates have increased in many populations.^[1]

Other less common causes include the use of barbiturates, which are sedative medications, and conditions such as Fanconi anemia and aplastic anemia, which are rare blood disorders. These conditions and medications have been linked to hepatic adenoma formation, though they account for a smaller number of cases.^[2]

Risk Factors

Understanding who is at higher risk for hepatic adenoma helps doctors identify patients who need closer monitoring. The most significant risk factor remains the use of estrogen-containing oral contraceptive pills. Women who take higher-dose estrogen formulations or who use birth control pills for longer periods face the greatest risk. Studies have shown that women over 30 years old who have used oral contraceptives for more than 25 months are at highest risk, with a 500-fold increased risk documented in those using the pills for more than 85 months.^[4]

Being female and of childbearing age automatically places someone in a higher risk group, given the strong association with hormonal contraception use during these years. However, men who use anabolic steroids for bodybuilding or athletic purposes also face elevated risk. The male gender itself carries implications for treatment, as men with hepatic adenoma have different outcomes and face different complication risks compared to women.^[1]

Obesity and being overweight have become recognized as important risk factors, especially for men. People with metabolic syndrome, which often includes obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels, are more likely to develop hepatic adenomas. This association has become more prominent as obesity rates have increased worldwide.^[1]

Individuals with type 1 diabetes face increased risk, as do people with certain rare genetic conditions. Type I and type III glycogen storage diseases significantly raise the likelihood of developing hepatic adenomas, often at younger ages. These genetic conditions affect how the body processes and stores sugar, leading to changes in the liver that promote tumor growth.^[1]

People taking certain medications beyond oral contraceptives also carry higher risk. This includes users of barbiturates, anabolic steroids, certain fertility drugs like clomiphene, and recombinant human growth hormones. Anyone taking these medications for extended periods should be aware of the potential for hepatic adenoma development.^[1]

Women who are pregnant or planning pregnancy need special consideration if they have risk factors for hepatic adenoma or have been previously diagnosed with these tumors. Pregnancy increases hormone levels naturally, which can cause existing adenomas to grow or increase the risk of complications such as bleeding.^[1]

Individuals with rare blood disorders such as Fanconi anemia or aplastic anemia also fall into higher-risk categories. People with a condition called hemochromatosis, where excess iron builds up in the blood and organs, may have increased susceptibility to hepatic adenoma as well.^[7]

Symptoms

One of the challenging aspects of hepatic adenoma is that it often produces no symptoms at all. About half of all people with these liver tumors do not experience any signs that something is wrong. Many cases are discovered accidentally when imaging tests such as ultrasounds or CT scans are performed for completely unrelated medical reasons.^[1] This silent nature of the condition means people can have hepatic adenomas for years without knowing.

When symptoms do occur, they tend to be mild and non-specific, making them easy to overlook or attribute to other causes. The most common symptom is pain or discomfort in the upper right side of the abdomen, where the liver is located. This pain can also appear in the epigastric region, which is the upper central part of the abdomen just below the ribcage. Some people notice a sense of fullness or bloating in their stomach area, even when they have not eaten much.^[1]

In some cases, patients or their doctors can feel a lump or mass during a physical examination of the abdomen. This typically happens when the tumor has grown to a larger size. The liver itself may feel enlarged when a doctor presses on the abdomen. These physical findings often prompt further investigation with imaging tests.^[21]

Nausea is another symptom that some patients experience, particularly when the tumor grows large enough to put pressure on surrounding organs and tissues. The pressure effects can create discomfort and interfere with normal digestive processes, leading to feelings of queasiness or loss of appetite.^[7]

The risk of rupture and bleeding is not the same for all hepatic adenomas. Larger tumors—generally those bigger than five centimeters—have a higher tendency to rupture and cause serious complications. Pregnant women face particularly high risk because the hormonal changes during pregnancy can cause adenomas to grow rapidly and become more prone to bleeding. Women who have recently taken hormone medications and those with a specific type called inflammatory hepatic adenoma also have higher chances of experiencing these dangerous complications.^[1]

The symptoms of a ruptured hepatic adenoma can develop suddenly and progress quickly. Internal bleeding from a ruptured tumor can lead to hypovolemic shock, which is a life-threatening condition where the body does not have enough blood volume to function properly. This manifests as extreme weakness, confusion, rapid heartbeat, pale or clammy skin, and loss of consciousness. Without emergency treatment, this situation can be fatal.^[2]

Prevention

Preventing hepatic adenoma focuses primarily on addressing the known risk factors that contribute to its development. Since oral contraceptive use is the leading cause in women, making informed choices about birth control represents an important prevention strategy. Women should discuss with their healthcare providers the risks and benefits of different contraceptive methods, especially if they have other risk factors such as obesity or a family history of liver problems.^[1]

For women who choose to use oral contraceptives, selecting formulations with lower doses of estrogen may help reduce risk. Modern birth control pills typically contain much less estrogen than older versions, which has likely contributed to a decrease in hepatic adenoma incidence over time. However, even low-dose pills carry some level of increased risk compared to not using hormonal contraception at all.^[4]

Limiting the duration of oral contraceptive use is another consideration. Since the risk of hepatic adenoma increases with longer use, women who have been on birth control pills for many years might want to discuss alternative contraceptive methods with their doctors. This is particularly relevant for women over 30 years old, who face higher risk with prolonged use.^[4]

Maintaining a healthy body weight through balanced nutrition and regular physical activity serves as an important preventive measure, especially for men. Obesity and metabolic syndrome are increasingly recognized as contributors to hepatic adenoma, so addressing these conditions can lower risk. Weight management through healthy lifestyle changes benefits overall liver health and reduces the likelihood of many liver-related problems.^[1]

Men should avoid using anabolic steroids unless prescribed by a doctor for legitimate medical reasons. The illegal use of these substances for bodybuilding or athletic performance enhancement carries significant health risks, including the development of hepatic adenomas. Other medications that affect hormone levels, such as certain fertility drugs, should only be used under medical supervision and for the shortest duration necessary.^[1]

People with genetic conditions that increase risk, such as glycogen storage diseases, need regular medical monitoring even if they cannot change their underlying condition. Early detection through routine imaging can identify hepatic adenomas before they cause complications. Similarly, individuals with diabetes, hemochromatosis, or blood disorders should work closely with their healthcare providers to manage their conditions optimally.^[1]

For women who are pregnant or planning pregnancy, discussing any history of oral contraceptive use or previous liver issues with their obstetric care team is important. Special monitoring may be needed during pregnancy if hepatic adenomas are suspected or have been previously diagnosed, since the hormonal changes of pregnancy can affect these tumors.^[1]

There is no specific screening program for hepatic adenoma in the general population because the condition is so rare. However, people with multiple risk factors might benefit from discussing with their doctors whether periodic liver imaging would be appropriate. This individualized approach to monitoring can help catch tumors early, when they are smaller and less likely to cause complications.^[10]

Pathophysiology

Hepatic adenoma is a benign epithelial tumor that originates from hepatocytes, which are the main functional cells of the liver. These tumors develop as a result of abnormal cell growth, but unlike cancerous tumors, they do not spread to other parts of the body. However, they can still cause serious problems because of their location in the liver and their tendency to grow, bleed, or rarely transform into cancer.^[2]

The tumors typically appear as well-defined, rounded masses within otherwise normal liver tissue. They lack a protective outer covering called a capsule, which distinguishes them from some other types of liver growths. Most hepatic adenomas are single tumors, though some people develop multiple adenomas. When someone has ten or more of these tumors, the condition is called hepatic adenomatosis.^[2]

Under the microscope, hepatic adenomas show distinctive features that help pathologists identify them. The tumor cells are large and filled with glycogen and fat, giving them a bubbly appearance. These cells are arranged in organized sheets or plates, which is different from the normal architecture of liver tissue. A key identifying feature is the absence of portal triads, which are structures in healthy liver tissue that contain blood vessels and bile ducts. The lack of these normal structures helps distinguish hepatic adenomas from other benign liver conditions.^[5]

The tumors are crossed by blood vessels but do not have the normal central veins or portal tracts that characterize healthy liver tissue. This altered blood vessel arrangement contributes to the risk of bleeding. Large blood vessels within the tumor can rupture, especially when the adenoma grows to a substantial size or is influenced by hormonal changes.^[5]

Hepatic adenomas are classified into four main subtypes based on their genetic and molecular characteristics, and these subtypes have different behaviors and risks. The inflammatory type, which accounts for 40 to 50 percent of cases, is characterized by activation of inflammatory pathways in the cells. These tumors are usually found in women and are associated with obesity and alcohol use.^[1]

The HNF-1α inactivated type makes up 35 to 40 percent of hepatic adenomas and is almost exclusively seen in women. These tumors are characterized by changes in a gene called HNF-1α, which affects how liver cells handle fats. This type generally has a lower risk of complications such as bleeding or cancer transformation.^[1]

The beta-catenin activated type represents 15 to 20 percent of cases and is more common in men. This subtype carries the highest risk of transforming into liver cancer because it involves mutations in genes that control cell growth and division. The beta-catenin protein, when abnormally activated, can drive cells toward cancerous behavior.^[1]

About 10 percent of hepatic adenomas cannot be classified into any of these categories and are labeled as unclassified. Researchers continue to study these tumors to better understand their characteristics and risks.^[1]

Hormones play a central role in the development and growth of hepatic adenomas. Estrogen and other sex hormones appear to stimulate the growth of hepatocytes, leading to the formation of these tumors. This explains why hepatic adenomas are so strongly associated with oral contraceptive use and pregnancy, both of which involve elevated hormone levels. When hormone exposure stops—such as when a woman discontinues birth control pills—many hepatic adenomas shrink in size, though they rarely disappear completely.^[8]

The size of hepatic adenomas varies widely, from less than one centimeter to as large as 30 centimeters, roughly the size of a large potato. Tumors typically measure between 8 and 15 centimeters when discovered. The size of the tumor directly relates to the risk of complications—larger tumors are much more likely to rupture and bleed than smaller ones.^[3]

Hepatic adenomas can occur anywhere in the liver but are more commonly found in the right lobe, which is the larger of the liver’s two main sections. The tumors receive their blood supply from the hepatic artery rather than from the portal vein, which is different from normal liver tissue. This arterial blood supply contributes to their tendency to bleed.^[4]

The risk of malignant transformation—meaning the tumor changes from benign to cancerous—occurs in about 5 percent of hepatic adenomas overall. This risk is higher in certain groups, particularly men, people with larger tumors, and those with beta-catenin activated adenomas. The transformation typically results in hepatocellular carcinoma, which is the most common type of primary liver cancer. This is why careful monitoring and, in some cases, surgical removal of hepatic adenomas is recommended even though most remain benign.^[1]

In people with glycogen storage diseases, the mechanism of hepatic adenoma formation relates to abnormal accumulation of glycogen in liver cells. This metabolic disturbance creates an environment that promotes tumor development. Similarly, in obesity and metabolic syndrome, insulin resistance and altered fat metabolism in the liver may contribute to hepatic adenoma formation.^[2]